文献速递急性肾损伤肾小球疾病

免疫检查点抑制剂相关肾血管炎及寡免疫复合物肾小球肾炎

Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors.
PubMed 文献 · Am J Kidney Dis · 2019-06-14

本文报道4例免疫检查点抑制剂治疗后出现的肾血管炎或寡免疫复合物肾小球肾炎,其中3例为肾小至中等血管炎,1例为局灶新月体性寡免疫复合物肾小球肾炎。3例表现为急性肾损伤,1例表现为肾病综合征和血尿。3例检测抗中性粒细胞胞浆抗体均为阴性。从启动检查点抑制剂至出现免疫相关不良事件的时间为2周至24个月。3例接受糖皮质激素治疗并获得临床缓解。

要点

  • 免疫检查点抑制剂相关肾血管炎和寡免疫复合物肾小球肾炎是肾功能下降的鉴别诊断之一。
  • 可表现为急性肾损伤或肾病综合征伴血尿,ANCA检测可能阴性。
  • 糖皮质激素治疗可使部分患者获得临床缓解。

核心结论

  • 肾血管炎和寡免疫复合物肾小球肾炎是检查点抑制剂相关肾功能下降的重要鉴别诊断。

研究设计与样本

  • 病例系列,报告4例接受检查点抑制剂治疗后出现肾血管炎或寡免疫复合物肾小球肾炎的患者。

主要发现

  • 3例为肾小至中等血管炎,1例为局灶新月体性寡免疫复合物肾小球肾炎。
  • 3例表现为急性肾损伤,1例表现为肾病综合征和血尿。
  • 3例检测抗中性粒细胞胞浆抗体均为阴性。
  • 从检查点抑制剂启动至免疫相关不良事件出现的时间为2周至24个月。
  • 3例接受糖皮质激素治疗并达到临床缓解。

临床怎么用

  • 对使用检查点抑制剂后出现肾功能下降的患者,应鉴别肾血管炎和寡免疫复合物肾小球肾炎。
  • 即使ANCA阴性,也不能排除检查点抑制剂相关肾血管炎或寡免疫复合物肾小球肾炎。
  • 糖皮质激素可用于治疗检查点抑制剂相关肾血管炎或寡免疫复合物肾小球肾炎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune checkpoint inhibitors are increasingly used to treat a variety of solid-organ and hematologic cancers. However, overactivation of the immune system can lead to immune-related adverse events, which are increasingly recognized in the kidney. There have been only rare reported cases of checkpoint inhibitor-associated glomerulonephritis and renal vasculitis, although vasculitis in other organs has been well described. We report 4 cases of renal vasculitis or pauci-immune glomerulonephritis after checkpoint inhibitor therapy. Three patients had renal small- to medium-vessel vasculitis and 1 had focally crescentic pauci-immune glomerulonephritis. Three patients presented with acute kidney injury, and 1 presented with nephrotic syndrome and hematuria. Three patients were tested for antineutrophil cytoplasmic antibodies, which were negative. The time from checkpoint inhibitor initiation to immune-related adverse event presentation ranged from 2 weeks to 24 months. Three patients were treated with glucocorticoids, resulting in clinical resolution. Our series demonstrates that renal vasculitis and pauci-immune glomerulonephritis are important considerations in the differential diagnosis of checkpoint inhibitor-related reductions in kidney function.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Gallan AJ, Alexander E, Reid P, et al. Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors. Am J Kidney Dis. 2019. PMID: 31204194. doi:10.1053/j.ajkd.2019.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。